Earnings Call · Q1 FY2022·2022-05-05

Q1 22EPS -35.48%·Rev n/aQ4 21EPS 0.00%·Rev n/aQ3 21EPS +14.29%·Rev n/aQ2 21EPS +76.47%·Rev n/a⚠ consensus missing

CORCEPT THERAPEUTICS INC CORT

Atabak Mokari — Chief Financial Officer

Charlie Robb — Chief Commercial Officer

Joseph Belanoff — Chief Executive Officer

−4.1%1d on move date−0.5% vs SPY3d−16.7%5d−22.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CORT calls or request research access.

More CORT calls Browse calls Request research access